United Kingdom Biotechnology & Medical Research

Futura Medical PLC (FUM)

Track

Track

Futura Medical PLC experienced significant insider buying activity on September 25, 2026, with four key executives, including the CEO and Chairman, acquiring shares totaling 47,000 GBP. This cluster of purchases follows a period where the stock price declined by 54.3% over the last quarter, occurring well after the company's most recent April 2026 earnings report.
Ticker: FUM Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Futura Medical PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
Ken James Executive Director and Head of R&D Executive Director
Transaction date
Purchase
Price
238.54
Quantity 42,893
Value £3,390,218
Roy Davis Non-Executive Director Executive Director
Transaction date
Purchase
Price
334.26
Quantity 7,237
Value £4,070,099
1.7
Andrew Unitt Non-Executive Chairman Director
Transaction date
Purchase
Price
476.09
Quantity 46,136
Value £4,383,983
Alexander Duggan Chief Executive Officer Officer
Transaction date
Purchase
Price
0.00
Quantity 1,000
Value £100,000
2.4
Angela Hildreth FD/COO Officer
Transaction date
Purchase
Price
0.01
Quantity 500,000
Value £5,000
2.4
Ken James Executive Director and Head of R&D Executive Director
Transaction date
Purchase
Price
0.01
Quantity 500,000
Value £5,000
Alex Duggan Chief Executive Officer Officer
Transaction date
Purchase
Price
0.01
Quantity 5,000,000
Value £50,000
3.1
Harmesh Suniara Non-Executive Director Executive Director
Through Lombard Odier Asset Management (Europe) Limited, a closely affiliated person
Transaction date
Sale
Price
0.02
Quantity 4,441,678
Value £66,625
James Barder Chief Executive Officer Officer
Transaction date
Sale
Price
0.41
Quantity 250,000
Value £101,657
2.4
Ken James Executive Director and Head of R&D Executive Director
Transaction date
Sale
Price
0.41
Quantity 200,000
Value £81,326
James Barder Chief Executive Officer Officer
Transaction date
Sale
Price
0.41
Quantity 250,000
Value £101,657
1.7
Andrew Unitt Director Executive Director
Transaction date
Purchase
Price
0.36
Quantity 26,526
Value £9,645
Jeff Needham Director Executive Director
Transaction date
Purchase
Price
0.36
Quantity 16,344
Value £5,943
John Clarke Director Executive Director
Transaction date
Purchase
Price
0.36
Quantity 44,560
Value £16,202
James Barder Chief Executive Officer Officer
Transaction date
Sale
Price
0.45
Quantity 250,000
Value £113,000
2.4
Jonathan Freeman Director Executive Director
Transaction date
Purchase
Price
0.12
Quantity 46,564
Value £5,699
John Clarke Director Executive Director
Transaction date
Purchase
Price
0.12
Quantity 129,754
Value £15,882
James Barder CEO Officer
Transaction date
Sale
Price
0.12
Quantity 173,000
Value £19,930
James Barder CEO Officer
Transaction date
Sale
Price
0.12
Quantity 173,000
Value £19,895
James Barder Chief Executive Officer Officer
Transaction date
Purchase
Price
0.08
Quantity 125,000
Value £10,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-29 2026-09-25 B Purchase
2.4
Ken James

Executive Director and Head of R&D

Executive Director
42,893
238.54
£3,390,218 		42,893 238.54 £3,390,218
2026-09-29 2026-09-25 B Purchase
Roy Davis

Non-Executive Director

Executive Director
7,237
334.26
£4,070,099 		7,237 334.26 £4,070,099
2026-09-29 2026-09-25 B Purchase
1.7
Andrew Unitt

Non-Executive Chairman

Director
46,136
476.09
£4,383,983 		46,136 476.09 £4,383,983
2026-09-29 2026-09-25 B Purchase
Alexander Duggan

Chief Executive Officer

Officer
1,000
0.00
£100,000 		1,000 0.00 £100,000
2025-12-08 2025-12-04 B Purchase
2.4
Angela Hildreth

FD/COO

Officer
500,000
0.01
£5,000 		500,000 0.01 £5,000
2025-12-08 2025-12-04 B Purchase
2.4
Ken James

Executive Director and Head of R&D

Executive Director
500,000
0.01
£5,000 		500,000 0.01 £5,000
2025-12-08 2025-12-04 B Purchase
Alex Duggan

Chief Executive Officer

Officer
5,000,000
0.01
£50,000 		5,000,000 0.01 £50,000
2025-11-14 2025-11-13 S Sale
3.1
Harmesh Suniara

Non-Executive Director

Through Lombard Odier Asset Management (Europe) Limited, a closely affiliated person Executive Director
4,441,678
0.02
£66,625 		4,441,678 0.02 £66,625
2024-09-13 2024-09-12 S Sale James Barder

Chief Executive Officer

Officer
250,000
0.41
£101,657 		250,000 0.41 £101,657
2024-09-13 2024-09-12 S Sale
2.4
Ken James

Executive Director and Head of R&D

Executive Director
200,000
0.41
£81,326 		200,000 0.41 £81,326
2024-09-13 2024-09-12 S Sale James Barder

Chief Executive Officer

Officer
250,000
0.41
£101,657 		250,000 0.41 £101,657
2023-01-12 2023-01-11 B Purchase
1.7
Andrew Unitt

Director

Executive Director
26,526
0.36
£9,645 		26,526 0.36 £9,645
2023-01-12 2023-01-11 B Purchase
Jeff Needham

Director

Executive Director
16,344
0.36
£5,943 		16,344 0.36 £5,943
2023-01-12 2023-01-11 B Purchase
John Clarke

Director

Executive Director
44,560
0.36
£16,202 		44,560 0.36 £16,202
2022-09-16 2022-09-15 S Sale James Barder

Chief Executive Officer

Officer
250,000
0.45
£113,000 		250,000 0.45 £113,000
2021-04-14 2021-04-14 B Purchase
2.4
Jonathan Freeman

Director

Executive Director
46,564
0.12
£5,699 		46,564 0.12 £5,699
2021-04-14 2021-04-14 B Purchase
John Clarke

Director

Executive Director
129,754
0.12
£15,882 		129,754 0.12 £15,882
2020-04-22 2020-04-22 S Sale James Barder

CEO

Officer
173,000
0.12
£19,930 		173,000 0.12 £19,930
2020-04-22 2020-04-22 S Sale James Barder

CEO

Officer
173,000
0.12
£19,895 		173,000 0.12 £19,895
2019-12-23 2019-12-23 B Purchase James Barder

Chief Executive Officer

Officer
125,000
0.08
£10,000 		125,000 0.08 £10,000
Explore more

More insider trading research around Futura Medical PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe